Framingham's Michael Cannon Vying For Man Of The Year Title

Framingham resident Michael Cannon has been nominated as a candidate for The Leukemia & Lymphoma Society’s Man & Woman of the Year campaign.

Cannon and 9 others in Massachusetts are competing to see who can raise the most money for the organization within a 10-week time period. The deadline is in 2 weeks and 2 days.

Money raised during the campaign will advance The Leukemia & Lymphoma Society’s mission to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.

Every dollar each candidate raises counts as one vote.

The candidates with the most votes will be awarded the titles 2015 Man & Woman of the Year.

To help Cannon’s campaign and to donate, click here. (Link: http://www.mwoy.org/pages/ma/ma15/mcannon)

Cannon, who is a Framingham Town Meeting member from Precinct 9 and works for Regent Capital Group Companies, has some tough competition this year.

One of his fellow nominees for Man of the Year is Liam Fitzgerald, the first-bumping Boston Bruins kid. Click here for all 10 nominees.

All donations are tax deductible.

The event, in its 13th year in Massachusetts, hopes to raise $600,000 in Massachusetts and more than $30 million nationally. Last year, $30.5 million was raised nationally by 900 candidates.

“We are looking forward to another successful campaign and are thrilled that Michael is part of it,” says Sharon Klein,
Executive Director of the Massachusetts Chapter. “We know that these candidates, like those before them, will give
tirelessly of themselves to further our cause.“

More than 400 people are expected to attend the Grand Finale Celebration at the Sheraton Boston Hotel on May 21.
The night begins with a silent auction and reception, followed by the event program and dinner.

The 2015 Man & Woman of the Year campaign is generously supported by Dana Farber Cancer Institute and Takeda
Oncology.

The funds raised through Man & Woman of the Year campaigns are used in many ways, including

• The continuing research and development of breakthrough therapies.
• Free blood cancer information, education and support.
• To support patients in their communities through our 61 chapters across the U.S. and Canada.
• To drive policies that accelerate the development and approval of new treatments.
• To advocate for blood cancer survivors and their families, helping patients navigate their cancer treatments and ensuring that they have access to quality, affordable and coordinated care